Current therapies for chronic hepatitis B virus (HBV) infection can effectively suppress viral replication but do not achieve ...

Vir Biotech's hepatitis B therapy shows 4% cure rate with doublet (tobevibart/elebsiran) and 10% with triplet therapy, below ...

Vir is holding off on advancing the combination therapy to Phase III trials until it secures a development partner.

Discover a study that raises important concerns about the long-term mental health of individuals with resolved HBV infection.

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational ...

Sanofi fabrica en el país uno de los nueve antígenos que componen la vacuna contra la hepatitis B; invirtió más de US$70 ...

Por asesoramiento personalizado o consulta de Planes Corporativos escribinos a [email protected]. Whatsapp al ...

Mayor Rex Richardson highlighted the new addition of free Hepatitis B vaccines to the lineup of no-cost resources available during the May 3 event, as per the details shared by the City of Long ...

1 in 20 Philly residents have reported testing positive for hepatitis B and hepatitis C, but the actual numbers may be even higher, since many cases go undetected. The Philadelphia Department of ...